Clinical Trials Directory

Trials / Sponsors / Kowa Research Institute, Inc.

Kowa Research Institute, Inc.

Industry · 46 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Ch
Primary Biliary Cholangitis, Compensated Cirrhosis
Phase 12024-10-01
Active Not RecruitingStudy to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangi
Primary Biliary Cholangitis
Phase 22024-02-07
CompletedA Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Desc
Fuchs Endothelial Corneal Dystrophy
Phase 32023-05-11
CompletedA Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuch
Fuchs Endothelial Corneal Dystrophy
Phase 32023-03-30
CompletedStudy to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadmin
Healthy
Phase 12023-02-24
Active Not RecruitingStudy to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
NASH
Phase 22022-11-14
CompletedA Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery
Corneal Edema After Cataract Surgery
Phase 32022-08-04
CompletedA Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dr
Dry Eye Disease
Phase 32022-07-03
CompletedStudy to Assess the Food Effect of K-877 in Healthy Adult Volunteers
Healthy
Phase 12021-01-13
TerminatedA Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed On
Acute Pain
Phase 22020-08-15
CompletedStudy to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FE
Fuchs' Endothelial Corneal Dystrophy
Phase 22020-06-23
CompletedStudy to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR
Dyslipidemia
Phase 22020-06-10
CompletedPharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers
Healthy
Phase 12019-12-17
CompletedA Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Ey
Dry Eye Disease
Phase 22019-08-04
CompletedCompare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adu
Healthy
Phase 12018-10-05
CompletedEvaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy A
Healthy
Phase 12018-10-04
CompletedStudy to Compare Kowa OCT Bi-μ and the Optovue iVue 100
Glaucoma, Retinal Disease, Healthy
N/A2018-04-21
TerminatedPemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Type2 Diabetes, Dyslipidemia
Phase 32017-03-23
CompletedStudy to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and
Severe Hypertriglyceridemia
Phase 32016-11-28
CompletedStudy to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and
Severe Hypertriglyceridemia
Phase 32016-11-26
CompletedDrug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-
Healthy
Phase 12016-09-01
WithdrawnEfficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dy
Hyperlipidemia, Dyslipidemia
Phase 32016-02-01
CompletedDrug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodyna
Healthy
Phase 12016-01-01
WithdrawnSafety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia
Hyperlipidemia, Dyslipidemia
Phase 32016-01-01
CompletedA Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers
Hyperlipidemia
Phase 12015-12-01
CompletedDrug-Drug Interaction Study in Healthy Adult Volunteers
Healthy
Phase 12014-09-01
CompletedEvaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312
Dyslipidemia
Phase 12014-08-01
CompletedDrug-Drug Interaction Study in Health Adult Volunteers
Healthy
Phase 12014-08-01
CompletedDrug-Drug Interaction Study in Healthy Adult Volunteers
Healthy
Phase 12014-07-01
CompletedDrug-Drug Interaction Study in Healthy Adult Volunteers
Healthy
Phase 12014-06-01
CompletedDrug-Drug Interaction Study in Healthy Adult Volunteers
Healthy
Phase 12014-06-01
CompletedStudy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subje
Hyperlipidemia
Phase 12014-04-01
TerminatedAn Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or
Acute Pain From Ankle Sprain or Strain
Phase 32014-04-01
CompletedA Thorough Corrected QT Interval Trial
Dyslipidemia
Phase 12014-01-01
CompletedStudy Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
Safety and Tolerability
Phase 12013-05-01
CompletedDrug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin
Healthy
Phase 42011-05-01
CompletedDrug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin
Healthy
Phase 42011-04-01
CompletedA 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects
Dyslipidemia
Phase 42010-12-01
CompletedPrevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixe
Primary Dyslipidemia, Mixed Dyslipidemia
Phase 42010-10-01
CompletedDrug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on S
Healthy
Phase 42010-07-01
CompletedA Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitaglipt
Type 2 Diabetes
Phase 22010-07-01
CompletedA Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokine
Type 2 Diabetes Mellitus
Phase 12010-05-01
CompletedDrug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin
Healthy Volunteers
Phase 42010-01-01
CompletedSafety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus
Severe Renal Impairment
Phase 42009-12-01
CompletedA Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis
Atherosclerosis
Phase 22009-02-01
CompletedSafety and Efficacy of K-134 for the Treatment of Intermittent Claudication
Intermittent Claudication
Phase 22008-11-01